Global Biosimilars Market

Global Biosimilars Market Industry, Size, Share, Growth, Trends and Forecast, 2019–2029 January 2021

Report Snippet Chapter 1 : Table of Contents

Chapter 2: Market Purview

Chapter 3: Market Dynamics

Chapter 4: Global Biosimilars Market, By Product Class

Chapter 5: Global Biosimilars Market, By Application

Chapter 6: Global Biosimilars Market, By Region

Chapter 7: Competitive Analysis

Chapter 8: Company Profiles

Chapter 9: Future of Market

Chapter 10: About Us

Market Segmentation

Global Biosimilars Market

By Application

By Product Class    

Monoclonal Antibodies Recombinant Hormones Immunomodulators Anti-inflammatory Agents

    

By Region

Blood Disorders Growth Hormonal Deficiency Chronic and Autoimmune Disorders Oncology Other Applications

    

North America Europe Asia Pacific Latin America Middle East & Africa

Executive Summary (1/5) Table 2.1: Global Biosimilars Market Overview

Parameters

2019 (E)

2029 (F)

Global Biosimilars Market Value (US$ Bn)

9.0 Bn

xxBn

Monoclonal Antibodies: XXX.X

By Product Class Value (US$ Mn)

Segment

with

Largest

By Product Class Segment CAGR (%)-2019-2029

with

Highest

By Application Value (US$ Mn)

Segment

with

Largest

By Application Segment with Highest CAGR (%)-2019-2029 By Region (US$ Mn)

Segment

with

Largest

Value

By Region Segment with Highest CAGR (%)2019-2029

CAGR- XX.X Oncology : XXX.X

Oncology : XXX.X

CAGR- XX.X North America : XXX.X

North America : XXX.X

Asia Pacific: CAGR- XX.X

Executive Summary (2/5) Table 2.2: Global Biosimilars Market Overview

Key Market Players:

Pfizer Inc. Eli Lilly and Company Mylan NV Novartis AG Teva Pharmaceutical Intas Samsung Biologics Co. Ltd Amgen Celltrion Inc. STADA Arzneimittel Aktiengesellschaft

Executive Summary (3/5) Description

Figure 2.1: Global Biosimilars (%), By Product Class – 2019 (E)

 The global biosimilars market was valued at USD 7,091.40 million in 2018, and is expected to reach a value of USD 30,109.95 million by 2024.

Value

Share

Monoclonal Antibodies Recombinant Hormones

 The market is also expected to register a CAGR of 27.29%, during the forecast period.  Several factors may be associated with the growth of the biosimilars market, such as several blockbuster biopharmaceuticals that are going off-patent over the next five to ten years, high growth potential, and increasing demand for biosimilar drugs due to their cost effectiveness.

Market

Immunomodulato rs

Figure 2.2: Global Biosimilars (%), By Application – 2019 (E)

Market

Value

Share

Blood Disorders Growth Hormonal Deficiency Chronic and Autoimmune Disorders Oncology

Executive Summary (4/5) Figure 2.3: Global Biosimilars (%), By Region – 2019 (E)

Market

Value

Share

North America

XX.X%

Europe

Latin America

Asia Pacific

Middle East & Africa

Analysis and Outcome

 On region the global immune health supplements market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The European region is dominating the immune health supplements market followed by the Asia Pacific.

 The United States entered this market only in 2015, when the first drug, Zarxio, manufactured by Sandoz, was approved by the FDA. In April 2017, the FDA approved the fifth biosimilar, RENFLEXIS (infliximab abda), under a global biosimilars development and commercialization agreement between Merck and Samsung  Bioepis Co. Ltd. Due to this aggressive strategy from both manufacturers and regulatory authorities, the size of the US biosimilar segment skyrocketed over the last two years. This trend of growth is expected to continue over the forecast period, as a huge number of blockbuster drugs, which garner sales of billions of US dollars, are about to lose their patents during the next two to three years.

 The recent patent expiration of major biologics has significantly helped the biosimilars business across the United Kingdom. past three years have observed Copyright © The PROPHECY MARKET INSIGHTS 2021, All Rights Reserved consistent growth in the sales of renowned

Executive Summary (5/5) Market at Glance

27.29%

xxBn

CAGR 019-2029

2029

9.0Bn 2019

Chapter 3

Market Dynamics

About Us Disclaimer  The material is based on sources which we believe are reliable, but no warranty, either expressed or implied, is provided in relation to the accuracy or completeness of the information. The views expressed are our best judgment as of the date of issue and are subject to change without notice. Prophecy Market Insights takes no responsibility for decisions made on the basis of these opinions.  Any redistribution of this information is strictly prohibited. Copyright © 2019 Prophecy Market Insights pvt. Ltd , all rights reserved. Legal and Copyright Notices  While the editors endeavor to ensure the accuracy of all information and data contained in this Market Research Report, neither they nor Prophecy Market Insights Pvt. Ltd. accept responsibility for any loss or damage (whether direct or indirect) whatsoever to the customer or any third party resulting or arising there from.  All rights reserved. No part of this publication may be reproduced or used in any form or by any means graphic, electronic or mechanical, including photocopying, recording, taping, or information storage and retrieval systems without permission of the publisher. Disclaimer: Prophecy market Insights Pvt. Ltd attempts to ensure that the information provided in our market research reports is as accurate and complete as possible, the quantity of detailed information used and the fact that some of the information (which cannot always be verified or validated) is supplied by third parties and sources not controlled by prophecy market Insights Pvt. ltd means that we cannot always guarantee the accuracy, completeness or originality of the information in some reports, and we are therefore not responsible for any errors or omissions in those reports. The recipients of these reports are responsible for determining whether the information contained therein is sufficient for use and shall use their own skill and judgement when choosing to rely upon the reports Copyright © PROPHECY MARKET INSIGHTS 2021, All Rights Reserved

To know more about us, please visit our website:

www.prophecymarketinsights.com For sales queries or new topics email us on:

sales@prophecymarketinsights.com For other queries contact:

Shweta R Email: shweta.r@prophecymarketinsights.com (Global Head - Business Development)

Prophecy Market Insights Email: sales@prophecymarketinsights.com

Turn static files into dynamic content formats.

Create a flipbook